If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

Share Price Information for Mobeus I&g (MIX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.00
Bid: 50.50
Ask: 53.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.941%)
Open: 52.00
High: 52.00
Low: 52.00
Prev. Close: 52.00
MIX Live PriceLast checked at -
Mobeus Income & Growth VCT is an Investment Trust

To provide investors with a regular income stream, by way of tax-free dividends, generated from income and capital returns, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

10 Nov 2023 13:30

RNS Number : 1304T
Mobeus Income & Growth VCT PLC
10 November 2023
 

MOBEUS INCOME & GROWTH VCT PLC

("the Company")

LEI: 213800HKOSEVWS7YPH79

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2023

 

Mobeus Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 September 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30 September 2023

(unaudited)

At 30 June 2023

(unaudited)

Net assets attributable to shareholders

£102.94 million

£100.15 million

Shares in issue

165,644,278

156,718,602

Net asset value (NAV) per share

62.15 pence

60.12 pence

Cumulative dividends paid

161.80 pence

161.80 pence

Cumulative Total return (net asset value basis) per share since inception

223.95 pence

221.92 pence

 

The NAV per share has increased by 2.03 pence in the quarter (an increase of 3.4% from the NAV per share at 30 June 2023).

 

INVESTMENT ACTIVITY DURING THE PERIOD

New Investment during the period

On 26 July 2023, the Company completed a new investment of £0.49 million into Mable Therapy Limited, a digital health platform for speech therapy and counselling for children and young adults.

 

On 3 August 2023, the Company completed a new investment of £0.48 million into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

 

Further Investments during the period

On 4 July 2023, a follow on equity investment of £0.41 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

 

On 11 August 2023, a follow on loan investment of £0.15 million was made into Orri Limited, an intensive day care provider for adults with eating disorders.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

There has been no activity post-quarter.

 

SHARE BUYBACK DURING THE PERIOD

On 26 September 2023, the Company purchased 946,163 of its own ordinary shares at a price of 57.11 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

DIVIDEND DECLARED DURING THE PERIOD

On 21 September 2023, a second interim dividend of 4.50 pence per share in respect of the year ending 31 December 2023 was declared and was paid on 8 November 2023 to all Shareholders whose names were on the register on 29 September 2023. Payment of this interim dividend will reduce NAV per share (shown above) to 57.65 pence and increase cumulative dividends paid to 166.30 pence per share.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFMFDSEDSEFF
Date   Source Headline
31st Mar 20219:00 amRNSAdmission to AIM of Parsley Box Group plc
31st Mar 20217:00 amRNSAnnual Financial Report for 31 December 2020
26th Mar 20219:00 amRNSINVESTEE COMPANY – INTENTION TO FLOAT
2nd Mar 20219:00 amRNSUnaudited NAV & Admission to AIM of Virgin Wines
25th Feb 20219:30 amRNSInvestee Company - Intention to Float
12th Feb 20214:00 pmRNSDirector/PDMR Shareholding
17th Dec 202010:19 amRNSTransaction in Own Shares and Total Voting Rights
1st Dec 20203:05 pmRNSDirector Declaration
1st Dec 20203:00 pmRNSRealisation of Investment
17th Nov 20203:22 pmRNSInterim Management Statement - 3rd Quarter
21st Sep 20207:00 amRNSDirector/PDMR Shareholding
18th Sep 20204:15 pmRNSTransaction in Own Shares
11th Sep 20203:30 pmRNSHalf-year Report
7th Sep 20207:00 amRNSRealisation of Investment
17th Aug 20207:30 amRNSRealisation of Investment
2nd Jul 20209:16 amRNSTransaction in Own Shares
14th May 20202:30 pmRNS1st Quarter Results
12th May 20203:45 pmRNSResult of AGM
29th Apr 20201:00 pmRNSRevised Annual General Meeting Arrangements
15th Apr 202011:00 amRNSTransaction in Own Shares
7th Apr 20207:48 amRNSAnnual Financial Report
2nd Apr 20205:10 pmRNSIssue of Equity
2nd Apr 202010:00 amRNSDividend Declaration
30th Mar 202012:40 pmRNSPublication of Suppl.Prospcts
27th Mar 20207:00 amRNSNet Asset Value(s)
19th Mar 202012:00 pmRNSDirector Declaration - Non-Executive Appointment
25th Feb 20203:15 pmRNSPublication of Suppl.Prospcts
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
7th Feb 20206:40 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:37 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:36 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:34 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:30 pmRNSPublication of Suppl.Prospcts
3rd Feb 202011:30 amRNSTotal Voting Rights
8th Jan 20204:31 pmRNSFundraising Update
8th Jan 20204:20 pmRNSIssue of Equity & Total Voting Rights
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
13th Dec 20195:50 pmRNSDividend Declaration
12th Dec 201912:40 pmRNSTransaction in Own Shares
19th Nov 201912:00 pmRNSFundraising Update
6th Nov 20195:20 pmRNS3rd Quarter Results
6th Nov 20195:00 pmRNSDividend Declaration
25th Oct 20194:00 pmRNSPublication of a Prospectus
11th Oct 20193:00 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.